Today: 4 June 2026
Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

NEW YORK, June 4, 2026, 14:06 (EDT)

Grab Holdings’ U.S.-listed shares climbed on Thursday afternoon, taking back part of the prior session’s drop while large-cap tech was soft. Delayed market data showed GRAB at $3.51, up 10 cents, or 2.9%, after trading between $3.37 and $3.55 on volume of about 27.7 million shares.

The move matters because Grab is near the point where investors are testing whether its ride-hailing, delivery and lending growth can survive higher fuel costs and tougher regional regulation. It is not just a travel-and-food-delivery stock anymore; the market is treating it as a broader Southeast Asia platform bet.

The wider U.S. tape was split. Reuters reported the Dow hit an all-time high and the S&P 500 rose, while the Nasdaq fell as a Broadcom-led chip selloff weighed on technology shares; Dustin Thackeray, chief investment officer at Crewe Advisors, said chips were due “for a bit of a breather.” Reuters

QQQ, an exchange-traded fund that tracks large Nasdaq stocks, slipped 0.27%, while DIA, a Dow-linked ETF, rose about 1.55%. That made Grab’s gain look more like selective buying in platform shares than a clean risk-on move across growth stocks.

Peer trading was firmer. Ride-hailing names Uber and Lyft also rose, up about 0.4% and 0.7%, respectively, giving Grab some company even as chip and software sentiment cooled.

Grab’s May 5 first-quarter report is still the base case for the stock: revenue rose 24% from a year earlier to $955 million, on-demand GMV — gross merchandise value, the value of transactions on the platform before costs and adjustments — rose 24% to $6.1 billion, and adjusted EBITDA, a profit measure excluding interest, tax, depreciation, amortization and some company adjustments, grew 46% to $154 million. Chief Executive Anthony Tan called it a “strong start,” while finance chief Peter Oey said the quarter kept Grab “firmly on track” for full-year revenue guidance of $4.04 billion to $4.10 billion and adjusted EBITDA of $700 million to $720 million. Q4 Investors

Brokerage analysts are not all leaning the same way. MarketBeat reported Thursday that Zacks Research raised Grab to “hold” from “strong sell,” while noting a broader “moderate buy” consensus and an average target price of $6.19; it also cited recent target cuts from Mizuho and JPMorgan, even though both kept positive ratings. MarketBeat

The financial-services story is becoming a larger swing factor. A May 20 SEC filing showed Grab would consolidate Indonesian digital bank Superbank after a Singtel stake transfer lifts Grab’s direct and indirect ownership above 50%; Superbank serves more than 6 million customers and reported its first full-year profit in 2025, with assets up 72% and net interest income — lending revenue after interest costs — up 84% year on year in April. Alex Hungate, Grab’s president and chief operating officer, said the deal was about “deepening that model and extending its impact.” SEC

But the risk paragraph is not small. In prepared remarks, Tan said Grab had deployed targeted fuel rebates after fuel price volatility emerged in March, and the company also saw some softness in Mobility, particularly in the Philippines; if driver support lasts longer than expected, or if demand weakens in key markets, the margin improvement investors are underwriting could slow.

That leaves the stock in a narrow fight. The business is still showing double-digit growth and higher profitability, but the share price remains sensitive to fuel, regulation, fintech credit quality and whether the Superbank consolidation gives investors clearer guidance when Grab next updates the market.

Stock Market Today

  • LanzaTech JV Raises $75 Million in Hong Kong IPO, Shares Surge
    June 4, 2026, 2:26 PM EDT. LanzaTech Global's joint venture Beijing Shougang LanzaTech raised about $75 million through an initial public offering on the Hong Kong Stock Exchange. The company sold 40 million H-shares at roughly $1.86 per share, valuing the venture near $750 million. LanzaTech's stake adjusted to 8.38% post-IPO. The venture operates four commercial plants using LanzaTech's carbon recycling technology, reporting revenue between $77 million and $87 million from 2023 to 2025. Nasdaq-listed LanzaTech shares jumped over 26% to $6.90 following the listing, reflecting strong investor interest in sustainable fuel solutions.

Latest articles

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

Grab Stock Bounces While Nasdaq Sags—What Traders Are Waiting For Next

4 June 2026
Grab Holdings’ U.S. shares jumped 2.9% to $3.51 as investors weighed strong Q1 results—revenue up 24% to $955 million, adjusted EBITDA up 46% to $154 million—and the consolidation of Indonesia’s Superbank, now majority-owned by Grab, against risks from higher fuel costs and regional regulation, leaving the stock sensitive to further updates on profitability and fintech growth.
Goldman Sachs Jumps as Dow Sets New High

Goldman Sachs Jumps as Dow Sets New High

4 June 2026
Goldman Sachs shares surged 4.6% to $1,095.89, powering the Dow to an all-time high as investors rotated into financials; the move was amplified by Goldman’s high share price in the price-weighted Dow, while the bank’s lead role in the $75 billion SpaceX IPO and strong Q1 earnings added momentum, even as analysts flagged risks from high IPO valuations and geopolitical uncertainty.
Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

Celsius Drops in New York After Texas Inquiry Hits Alani Nu Play

4 June 2026
Celsius shares plunged 6.8% to near a 52-week low after Texas opened a probe into whether its Alani Nu drinks misled consumers about safety for minors, raising fresh legal and consumer-safety concerns just as the company relies on Alani Nu for growth and integration with PepsiCo’s distribution system.
Veru shares jump after Novo Nordisk deal draws traders

Veru shares jump after Novo Nordisk deal draws traders

4 June 2026
Veru shares soared 112% to $4.78 after announcing Novo Nordisk will supply Wegovy at no charge for Veru’s Phase 2b obesity trial, with Veru retaining global rights to enobosarm but granting Novo a right of first negotiation; analysts called the deal a “significant event” and kept $24–$25 targets, while Veru warned trial risks and reimbursement challenges remain.
CRISPR Therapeutics Jumps 12% in New York Trading

CRISPR Therapeutics Jumps 12% in New York Trading

4 June 2026
CRISPR Therapeutics shares soared 11.7% to $58.15 after presenting at the Jefferies Global Healthcare Conference, with sector momentum lifting gene-editing stocks and the SPDR S&P Biotech ETF up 3.0%. Casgevy, its key sickle cell therapy, posted $43 million Q1 revenue, but a $122.9 million net loss and biotech risks mean the rally hinges on investor appetite and upcoming clinical updates.
Goldman Sachs Jumps as Dow Sets New High
Previous Story

Goldman Sachs Jumps as Dow Sets New High

Go toTop